
Researchers, led by Chrishan J. Nalliah, explored whether continuous positive airway pressure (CPAP) therapy for obstructive sleep apnea (OSA) affected the remodeling of the atrial substrate associated with OSA in patients with atrial fibrillation. Their study, published in JACC: Clinical Electrophysiology, found that CPAP therapy appeared to reverse the atrial remodeling in atrial fibrillation.
The randomized controlled trial enrolled 24 patients referred for atrial fibrillation management with moderate or above OSA, defined as an apnea-hypopnea index (AHI) ≥15. Twelve patients received CPAP therapy and the remaining 12 received no therapy. The researchers used high-density right atrial mapping to assess atrial voltage, conduction velocity, atrial surface area <0.5 mV, proportion of complex points, and atrial effective refractory periods at baseline and after a minimum of 6 months.